By continuing to use this website, you agree to the use of cookies. You can find out more by following this link.

Our other therapy areas

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}

      • Image Overlay Teaser

      AbbVie Estonia

      From Micro to Macro

      In Estonia, a protocol is being developed to test, treat and follow up with adult hospital patients with elevated liver enzymes who are at risk for hepatitis C infection. Today, these patients are undiagnosed due to the lack of funding for screening.

      AbbVie Estonia

      From Micro to Macro

      In Estonia, a protocol is being developed to test, treat and follow up with adult hospital patients with elevated liver enzymes who are at risk for hepatitis C infection. Today, these patients are undiagnosed due to the lack of funding for screening.

      AbbVie Estonia

      From Micro to Macro

      In Estonia, a protocol is being developed to test, treat and follow up with adult hospital patients with elevated liver enzymes who are at risk for hepatitis C infection. Today, these patients are undiagnosed due to the lack of funding for screening.

      Teaser Inside Image

      AbbVie Germany

      Project Plus

      In Germany, a new referral network called Project Plus has been set up at addiction treatment centers. The network is helping people who inject drugs battle addiction, along with the other challenges they face, enabling them to prioritize seeking hepatitis C care.

      Read the Project Plus story

      AbbVie Germany

      Project Plus

      In Germany, a new referral network called Project Plus has been set up at addiction treatment centers. The network is helping people who inject drugs battle addiction, along with the other challenges they face, enabling them to prioritize seeking hepatitis C care.

      Read the Project Plus story

      This website belongs to internal AbbVie’s initiative and it reflects a possible experience our hcp could have in Abbvie Pro

      Copyright © 2019 AbbVie Inc. SKZD-190010 North Chicago, Illinois, U.S.A.

      Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.

      Data of Preparation: September 2019

      Approval code [approvalCode]